Efficacy of Selpercatinib in RET Fusion-Positive Non-Small-Cell Lung Cancer

A. Drilon, G. R. Oxnard, D. S.W. Tan, H. H.F. Loong, M. Johnson, J. Gainor, C. E. McCoach, O. Gautschi, B. Besse, B. C. Cho, N. Peled, J. Weiss, Y. J. Kim, Y. Ohe, M. Nishio, K. Park, J. Patel, T. Seto, T. Sakamoto, E. RosenM. H. Shah, F. Barlesi, P. A. Cassier, L. Bazhenova, F. De Braud, E. Garralda, V. Velcheti, M. Satouchi, K. Ohashi, N. A. Pennell, K. L. Reckamp, G. K. Dy, J. Wolf, B. Solomon, G. Falchook, K. Ebata, M. Nguyen, B. Nair, E. Y. Zhu, L. Yang, X. Huang, E. Olek, S. M. Rothenberg, K. Goto, V. Subbiah*, A. Drilon

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

114 Scopus citations

Fingerprint

Dive into the research topics of 'Efficacy of Selpercatinib in RET Fusion-Positive Non-Small-Cell Lung Cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences